Pooled evidence from 2 randomized trials and 6 observational cohorts suggests posttransplant gilteritinib maintenance may ...

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

In A Nutshell Among older adults carrying the APOE ε4 gene variant, the predominant genetic risk factor for Alzheimer’s ...

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

A large study in Nature Medicine finds GLP-1 drugs linked to lower heart and kidney risk in type 1 diabetes, without ...

Introduction Interstitial lung disease (ILD) is a serious extra-articular manifestation of rheumatoid arthritis (RA) ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart ...

Clinicians must balance maintaining lupus nephritis remission against the cumulative harms of long-term immunosuppressive therapy.

ChemR23 agonism targets inflammatory and neurosensory biology, with receptor expression on ocular immune cells and dorsal root ganglion neurons/glia supporting a mechanistic rationale for NCP symptom ...

A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.